Surgery Websites
LiverSource »  Faculty »  Hepatology »  Bilal Hameed, M.D.

Bilal Hameed, M.D.

Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 514-2860
415-476-0659
Bilal.Hameed@ucsf.edu
Open Popup
  • 1995-2000 Dow Medical College, M.B.B.S.
  • 2003-2006 University of Minnesota, Minneapolis, Internal Medicine Residency
  • 2006-2009 University of Minnesota, Minneapolis, Gastroenterology Fellowship

  • 2009-2010 University of California, San Francisco, Transplant Hepatology Fellowship
  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology
  • UCSF Liver Transplantation Program
  • Alcoholic Liver Disease
  • Autoimmune Hepatitis
  • Benign Liver Tumors
  • Cirrhosis
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Liver Transplantation
  • Living Donor Liver Transplantation
  • Nonalcoholic Fatty Liver Disease
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Epidemiology and management of NAFLD
  • Modeling outcomes in advanced liver disease and liver transplantation.
  • Sleep apnea in NAFLD

Bilal Hameed, M.D. is an Assistant Professor of Medicine and hepatologist at UCSF who treats patients with liver disease and plays an integral role in the multidisciplinary Liver Transplantation Program.

Dr. Hameed received his medical degree from Dow Medical College, completed an internal medicine residency at the University of Minnesota, and consecutive fellowships at the University of Minnesota and UCSF, in the areas of gastroenterology and transplant hepatology respectively. Dr. Hameed is board certified by the American Board of Internal Medicine with a general certificate in internal medicine and a subspeciality in gastroenterology.

Dr. Hameed is a member of American Association for the Study of Liver Diseases, American Gastroenterological Association. and American Society of Transplantation. He is author of numerous peer-reviewed articles and the recipient of many awards and honors in his field. He is also fluent languages of  Punjabi and Urdu.

Most recent publications from a total of 36
  1. Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 May 13. View in PubMed
  2. Leventhal TM, Gottfried M, Olson JC, Subramanian RM, Hameed B, Lee WM. Acetaminophen is Undetectable in Plasma From More Than Half of Patients Believed to Have Acute Liver Failure Due to Overdose. Clin Gastroenterol Hepatol. 2019 Feb 05. View in PubMed
  3. Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. Hepatology. 2019 Jan 19. View in PubMed
  4. Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2018 Nov 17. View in PubMed
  5. Kotwani P, Saxena V, Dodge JL, Roberts J, Yao F, Hameed B. History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist. Transplantation. 2018 05; 102(5):794-802. View in PubMed
  6. Azeem N, Ajmera V, Hameed B, Mehta N. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels. Hepatol Commun. 2018 04; 2(4):349-353. View in PubMed
  7. Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, Hameed B, Ganger D, Subramanian RM, Bukofzer S, Ravis WR, Clasen K, Sherker A, Little L, Lee WM. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. Hepatology. 2018 03; 67(3):1003-1013. View in PubMed
  8. Hameed B, Terrault NA, Gill RM, Loomba R, Chalasani N, Hoofnagle JH, Van Natta ML. Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2018 03; 47(5):645-656. View in PubMed
  9. Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol. 2018 Jun; 16(6):936-946. View in PubMed
  10. Aldawsari A, Khan MA, Hameed BH, Alqadami AA, Siddiqui MR, Alothman ZA, Ahmed AYBH. Mercerized mesoporous date pit activated carbon-A novel adsorbent to sequester potentially toxic divalent heavy metals from water. PLoS One. 2017; 12(9):e0184493. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Bilal Hameed, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

 

Site Directory
    X